Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study (10.1007/s13300-021-01133-8, 2021)

Basit Öğe Kaydı
dc.authoridDagdelen, Selcuk/0000-0002-0513-1750
dc.authoridSonmez, Alper/0000-0002-9309-7715
dc.authoridsahin, mustafa/0000-0002-4718-0083
dc.authoridSatman, Ilhan/0000-0001-8613-1797
dc.authoridTASCI, ILKER/0000-0002-0936-2476
dc.authorwosidDagdelen, Selcuk/A-9432-2017
dc.authorwosidŞahin, İbrahim/HHY-8303-2022
dc.authorwosidCelik, Osman/KLZ-6766-2024
dc.authorwosidSonmez, Alper/H-8588-2019
dc.authorwosidArga, Kazım Yalçın/HGB-8786-2022
dc.authorwosidsahin, mustafa/AAH-3394-2019
dc.authorwosidUnluturk, Ugur/A-1988-2016
dc.contributor.authorEmral, Rifat
dc.contributor.authorHaymana, Cem
dc.contributor.authorDemirci, Ibrahim
dc.contributor.authorTasci, Ilker
dc.contributor.authorSahin, Mustafa
dc.contributor.authorCakal, Erman
dc.contributor.authorAta, Naim
dc.date.accessioned2024-08-04T20:50:42Z
dc.date.available2024-08-04T20:50:42Z
dc.date.issued2021
dc.departmentİnönü Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.doi10.1007/s13300-021-01154-3
dc.identifier.endpage2872en_US
dc.identifier.issn1869-6953
dc.identifier.issn1869-6961
dc.identifier.issue11en_US
dc.identifier.pmid34559403en_US
dc.identifier.scopus2-s2.0-85115635106en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage2871en_US
dc.identifier.urihttps://doi.org/10.1007/s13300-021-01154-3
dc.identifier.urihttps://hdl.handle.net/11616/100217
dc.identifier.volume12en_US
dc.identifier.wosWOS:000698864600001en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSpringer Heidelbergen_US
dc.relation.ispartofDiabetes Therapyen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject[No Keywords]en_US
dc.titleLower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study (10.1007/s13300-021-01133-8, 2021)en_US
dc.typeCorrectionen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu